Ceratite

Rhee MK, Ahmad S, Amescua G, et al. Bacterial keratitis preferred practice pattern®. Ophthalmology. 2024 Apr;131(4):P87-133.Texto completo  Resumo

Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2014 Oct 16;(10):CD005430.Texto completo  Resumo

Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015 Jan 9;(1):CD002898.Texto completo  Resumo

1. Rhee DJ, Pyfer MF. The Wills eye manual. Baltimore: Lippincott, Williams & Wilkins, 1999.

2. Sharma S. Keratitis. Biosci Rep. 2001 Aug;21(4):419-44. Resumo

3. Ting DSJ, Ho CS, Deshmukh R, et al. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye (Lond). 2021 Apr;35(4):1084-101.Texto completo  Resumo

4. Rhee MK, Ahmad S, Amescua G, et al. Bacterial keratitis preferred practice pattern®. Ophthalmology. 2024 Apr;131(4):P87-133.Texto completo  Resumo

5. Cabrera-Aguas M, Khoo P, Watson SL. Infectious keratitis: a review. Clin Exp Ophthalmol. 2022 Jul;50(5):543-62.Texto completo  Resumo

6. Stapleton F. The epidemiology of infectious keratitis. Ocul Surf. 2023 Apr;28:351-63. Resumo

7. Guess S, Stone DU, Chodosh J, et al. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf. 2007 Jul;5(3):240-50. Resumo

8. Brown L, Leck AK, Gichangi M, et al. The global incidence and diagnosis of fungal keratitis. Lancet Infect Dis. 2021 Mar;21(3):e49-57. Resumo

9. Kinota S, Wong KW, Biswas J, et al. Changing patterns of infectious keratitis: overview of clinical and histopathologic features of keratitis due to Acanthamoeba or atypical Mycobacteria, and of infectious crystalline keratopathy. Indian J Ophthalmol. 1993 Apr;41(1):3-14. Resumo

10. Toshida H, Kogure N, Inoue N, et al. Trends in microbial keratitis in Japan. Eye Contact Lens. 2007 Mar;33(2):70-3. Resumo

11. Gomes BF, Santhiago MR. Biology of peripheral ulcerative keratitis. Exp Eye Res. 2021 Mar;204:108458. Resumo

12. American Academy of Ophthalmology. Fungal keratitis - Asia Pacific. Oct 2016 [internet publication].Texto completo

13. Labetoulle M, Boutolleau D, Burrel S, et al. Herpes simplex virus, varicella-zoster virus and cytomegalovirus keratitis: facts for the clinician. Ocul Surf. 2023 Apr;28:336-50. Resumo

14. Jhanji V, Young AL, Mehta JS, et al. Management of corneal perforation. Surv Ophthalmol. 2011 Nov-Dec;56(6):522-38. Resumo

15. Mathenge W. Emergency management: exposure keratopathy. Community Eye Health. 2018;31(103):69.Texto completo

16. Cullen AP. Photokeratitis and other phototoxic effects on the cornea and conjunctiva. Int J Toxicol. 2002 Nov-Dec;21(6):455-64.Texto completo  Resumo

17. Leccisotti A, Fields SV. Diffuse lamellar keratitis after LASIK with low-energy femtosecond laser. J Cataract Refract Surg. 2021 Feb 1;47(2):233-7. Resumo

18. Agrawal V, Biswas J, Madhavan HN, et al. Current perspectives in infectious keratitis. Indian J Ophthalmol. 1994 Dec;42(4):171-92.Texto completo  Resumo

19. Kaiser PK, Friedman NJ. The Massachusetts eye and ear infirmary illustrated manual of ophthalmology. New York (NY): Elsevier Science; 2004.

20. Hassanpour K, H ElSheikh R, Arabi A, et al. Peripheral ulcerative keratitis: a review. J Ophthalmic Vis Res. 2022 Apr-Jun;17(2):252-75.Texto completo  Resumo

21. Shahid SM, Ahmed SN, Khan Y. Eye problems in contact lens wearers. BMJ. 2019 Nov 27;367:l6337. Resumo

22. Zhang Y, Xu X, Wei Z, et al. The global epidemiology and clinical diagnosis of Acanthamoeba keratitis. J Infect Public Health. 2023 Jun;16(6):841-52.Texto completo  Resumo

23. Manikandan P, Abdel-Hadi A, Randhir Babu Singh Y, et al. Fungal keratitis: epidemiology, rapid detection, and antifungal susceptibilities of fusarium and aspergillus isolates from corneal scrapings. Biomed Res Int. 2019;2019:6395840.Texto completo  Resumo

24. Waghmare SV, Jeria S. A review of contact lens-related risk factors and complications. Cureus. 2022 Oct;14(10):e30118.Texto completo  Resumo

25. Szczotka-Flynn LB, Shovlin JP, Schnider CM, et al. American Academy of Optometry Microbial Keratitis Think Tank. Optom Vis Sci. 2021 Mar 1;98(3):182-98.Texto completo  Resumo

26. American Academy of Ophthalmology. Cornea/external disease summary benchmarks - 2023. Dec 2023 [internet publication].Texto completo

27. Tauber J, Sainz de la Maza M, Hoang-Xuan T, et al. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 1990 Jan;9(1):66-73. Resumo

28. Lin A, Ahmad S, Amescua G, et al. Blepharitis preferred practice pattern®. Ophthalmology. 2024 Apr;131(4):P50-86. Resumo

29. Narayanan S, Redfern RL, Miller WL, et al. Dry eye disease and microbial keratitis: is there a connection? Ocul Surf. 2013 Apr;11(2):75-92.Texto completo  Resumo

30. de Lacerda AG, Lira M. Acanthamoeba keratitis: a review of biology, pathophysiology and epidemiology. Ophthalmic Physiol Opt. 2021 Jan;41(1):116-35. Resumo

31. Jacobs DS, Lee JK, Shen TT, et al. Refractive surgery preferred practice pattern®. Ophthalmology. 2023 Mar;130(3):P61-135.Texto completo

32. Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017 Nov;124(11):1678-89.Texto completo  Resumo

33. Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2014 Oct 16;(10):CD005430.Texto completo  Resumo

34. Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012 Feb;130(2):143-50.Texto completo  Resumo

35. Lalitha P, Srinivasan M, Rajaraman R, et al. Nocardia keratitis: clinical course and effect of corticosteroids. Am J Ophthalmol. 2012 Dec;154(6):934-9. Resumo

36. Garg P, Vazirani J. Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea? Expert Rev Ophthalmol. 2013;8:41-4.

37. Hanet MS, Jamart J, Chaves AP. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. Can J Ophthalmol. 2012 Dec;47(6):493-9. Resumo

38. Patterson TJ, McKinney D, Ritson J, et al. The use of preoperative prophylactic systemic antibiotics for the prevention of endopthalmitis in open globe injuries: a meta-analysis. Ophthalmol Retina. 2023 Nov;7(11):972-81.Texto completo  Resumo

39. Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804.Texto completo  Resumo

40. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015 Jan 9;(1):CD002898.Texto completo  Resumo

41. Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Curr Eye Res. 2012 Jul;37(7):654-60. Resumo

42. FlorCruz NV, Evans JR. Medical interventions for fungal keratitis. Cochrane Database Syst Rev. 2015 Apr 9;(4):CD004241.Texto completo  Resumo

43. Raj N, Vanathi M, Ahmed NH, et al. Recent Perspectives in the Management of Fungal Keratitis. J Fungi (Basel). 2021 Oct 26;7(11):907.Texto completo  Resumo

44. Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008 Jul;92(7):871-8.Texto completo  Resumo

45. Alkharashi M, Lindsley K, Law HA, et al. Medical interventions for acanthamoeba keratitis. Cochrane Database Syst Rev. 2015 Feb 24;(2):CD010792.Texto completo  Resumo

46. Tu EY, Joslin CE, Shoff ME. Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy. Cornea. 2010 Sep;29(9):1066-8.Texto completo  Resumo

47. Cardine S, Bourcier T, Chaumeil C, et al. [Clinical management and prognosis in Acanthamoeba keratitis: a retrospective study of 25 cases]. [in fre]. J Fr Ophtalmol. 2002 Dec;25(10):1007-13. Resumo

48. Bang S, Edell E, Eghrari AO, et al. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. Am J Ophthalmol. 2010 Jan;149(1):66-9. Resumo

49. Moshirfar M, Somani SN, Tingey MT, et al. Marginal keratitis with secondary diffuse lamellar keratitis after small incision lenticule extraction (SMILE) after initiation of continuous positive airway pressure (CPAP) therapy. Int Med Case Rep J. 2020;13:685-9.Texto completo  Resumo

50. Dana R, Farid M, Gupta PK, et al. Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy. BMC Ophthalmol. 2021 Sep 8;21(1):327.Texto completo  Resumo

51. Papaioannou L, Miligkos M, Papathanassiou M. Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis. Cornea. 2016 Jan;35(1):62-71. Resumo

52. Davis SA, Bovelle R, Han G, et al. Corneal collagen cross-linking for bacterial infectious keratitis. Cochrane Database Syst Rev. 2020 Jun 17;6(6):CD013001.Texto completo  Resumo

53. Avdagic E, Chew HF, Veldman P, et al. Resolution of Acanthamoeba keratitis with adjunctive use of oral miltefosine. Ocul Immunol Inflamm. 2021 Feb 17;29(2):278-81. Resumo

54. Thulasi P, Saeed HN, Rapuano CJ, et al. Oral miltefosine as salvage therapy for refractory Acanthamoeba keratitis. Am J Ophthalmol. 2021 Mar;223:75-82. Resumo

55. Naranjo A, Martinez JD, Miller D, et al. Systemic miltefosine as an adjunct treatment of progressive Acanthamoeba keratitis. Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1576-84. Resumo

56. de la Presa M, Ibach M, Berdahl J, et al. Anterior scleral and limbal inflammatory necrosis after adjuvant miltefosine for recalcitrant acanthamoeba keratitis. Cornea. 2022 Jun 1;41(6):775-8. Resumo

57. Dart JKG, Papa V, Rama P, et al. The orphan drug for acanthamoeba keratitis (ODAK) trial: PHMB 0.08% (polihexanide) and placebo versus PHMB 0.02% and propamidine 0.1. ophthalmology. 2024 Mar;131(3):277-87.Texto completo  Resumo

58. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006 Jan;113(1):109-16. Resumo

59. Ti SE, Scott JA, Janardhanan P, et al. Therapeutic keratoplasty for advanced suppurative keratitis. Am J Ophthalmol. 2007 May;143(5):755-62. Resumo

60. Iyer SA, Tuli SS, Wagoner RC. Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens. 2006 Dec;32(6):267-71. Resumo

61. Labetoulle M, Auquier P, Conrad H, et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology. 2005 May;112(5):888-95. Resumo

62. Branco BC, Gaudio PA, Margolis TP. Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty. Br J Ophthalmol. 2004 Oct;88(10):1285-8. Resumo

63. Thebpatiphat N, Hammersmith KM, Rocha FN, et al. Acanthamoeba keratitis: a parasite on the rise. Cornea. 2007 Jul;26(6):701-6. Resumo

64. Bhatt UK, Abdul Karim MN, Prydal JI, et al. Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts. Cochrane Database Syst Rev. 2016 Nov 30;11:CD007824.Texto completo  Resumo